Patent · US Active

Mycoplasma hyopneumoniae vaccine

US10206991B2 · kind B2 · utility

4Cited by

51References

28Claims

0Family size

Assignee

ZOETIS SERVICES LLC · US

Inventors

Jeffrey E. Galvin · Lincoln, US
Gregory Paul Nitzel · Paw Paw, US
John Keith Garrett · North Wilkesboro, US
James R. Kulawik, II · Lincoln, US
Tracy L. Ricker · Portage, US
Megan Marie Smutzer · Kalamazoo, US

Key dates

Filing date	Apr 6, 2017
Grant date	Feb 19, 2019
Priority date	—
Expiry date	Apr 6, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2770/10034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides an immunogenic composition including the supernatant of a Mycoplasma hyopneumoniae (M.hyo) culture, wherein the supernatant of the M.hyo culture has been separated from insoluble cellular material by centrifugation, filtration, or precipitation and is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.